Philips continues to create awareness on sleep disorders

More than 100 million people globally suffer from obstructive sleep apnea (OSA). Sleep apnea is a common sleep disorder characterized by repeated interruptions in breathing throughout the sleep cycle. Chronic sleep or respiratory conditions can have devastating effects if not treated or diagnosed, and it is estimated that 80 percent of patients with OSA remain undiagnosed, which can impact long-term health by turning sleep or breathing into a burden.

According to a 2015 Philips Respironics survey that surveyed people in 10 countries, 96 percent said sleep was valuable to them and 87 percent ranked sleep as an influence on their overall health and wellbeing; however of those surveyed, only 17 percent consistently slept through the night.

In recent years, Philips has made a significant effort to encourage people to be screened for OSA and other sleep disorders. Globally, it is estimated that 100 million people suffer from OSA, with an overwhelming 80% of them remaining undiagnosed.